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Abstract
Objective—To determine whether individuals with primary ciliary dyskinesia (PCD) from
unrelated Amish and Mennonite families harbor a single and unique founder mutation.
Study design—Subjects from Amish and Mennonite communities in several states were
enrolled in the study. All subjects were clinically characterized, and nasal nitric oxide levels were
measured. Nasal epithelial scrapings were collected from several subjects for ciliary ultrastructural
analyses. DNA was isolated from patients with PCD and their unaffected first- and second-degree
relatives. Genome-wide homozygosity mapping, linkage analyses, targeted mutation analyses, and
exome sequencing were performed.
Results—All subjects from Old-Order Amish communities from Pennsylvania were
homozygous for a nonsense mutant DNAH5 allele, c.4348C>T (p.Q1450X). Two affected siblings
from an unrelated Mennonite family in Arkansas were homozygous for the same nonsense
DNAH5 mutation. Children with PCD from an Amish family from Wisconsin had biallelic
DNAH5 mutations, c.4348C>T (p.Q1450X) and c.10815delT (p.P3606HfsX23), and mutations in
other genes associated with PCD were also identified in this community.
Conclusion—The Amish and Mennonite subjects from geographically dispersed and socially
isolated communities had the same founder DNAH5 mutation, owing to the common heritage of
these populations. However, disease-causing mutations in other PCD-associated genes were also
found in affected individuals in these communities, illustrating the genetic heterogeneity in this
consanguineous population.
The first human genetic disorder associated with ciliary dysfunction, primary ciliary
dyskinesia (PCD) usually has an autosomal recessive mode of inheritance that leads to
functional and, in some cases, ultrastructural abnormalities of the cilia. Impaired ciliary
motility results in retention of inhaled particles and bacteria in the lung, paranasal sinuses,
and middle ear, which manifest as chronic bronchitis, pansinusitis, and suppurative otitis
media.1–4 Dysfunction of cilia outside of the sinopulmonary tract may cause male infertility
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owing to impaired movement of spermatozoa, and can play a role in laterality defects, such
as situs inversus totalis, related to motility defects of nodal cilia.1–4
The variable clinical presentation of PCD is likely related to the genetic heterogeneity of this
disease, which reflects the complexity of the ciliary structure. Cilia are composed of
hundreds of proteins, and their chemical and physical interactions are required for motility
to generate an effective and synchronous waveform.5–7 Mutations in any of these cilia
proteins could potentially result in functional impairment and a spectrum of clinical
manifestations. Genetic causes of PCD have been identified by sequencing human orthologs
of genes discovered by screening for ciliary dysfunction in model organisms, which have
provided insight into genotype–phenotype relationships in the human cilium. Using such
models, mutations in several different genes, including DNAI18–10 and DNAH5,11,12 have
been shown to cause PCD; these mutations account for disease in roughly half of all affected
individuals.
The Old-Order Amish and Mennonite populations in North America have a common social
heritage, descending from Swiss Anabaptist immigrants who emigrated seeking religious
tolerance in the eighteenth century. Starting from initial settlements in Pennsylvania, these
close-knit agrarian communities have spread across North America. Settlements maintain
strict adherence to religious customs, and because members rarely marry outside the church,
consanguinity is common. Families live in small endogamous communities that have
different allele frequencies and genetic diseases due to unique founders, resulting in closed
populations with a limited gene pool and an increased incidence of certain heritable
conditions.13–16 In previous studies of Old Order Amish and Amish-Mennonite
communities in the US, we discovered individuals with clinical manifestations consistent
with PCD from several unrelated communities. Owing to consanguinity present in these
geographically dispersed populations, we investigated the possibility that these communities
harbor unique founder mutations.
Methods
Subjects from Amish communities in the midwest with neonatal respiratory distress, situs
inversus totalis, chronic pneumonia, or rhinosinusitis were recruited to participate in the
study, which has been described previously.17 Two probands from an Old-Order Amish
community in Pennsylvania were enrolled and evaluated in a cross-sectional study supported
by the Genetic Diseases of Mucociliary Clearance Consortium, and other family members
with classic clinical features (Table I) were studied at the Clinic for Special Children. The
Mennonite subjects from Arkansas were also enrolled in studies administered by the Genetic
Diseases of Mucociliary Clearance Consortium and studied at the University of North
Carolina at Chapel Hill. Evaluations included detailed clinical and family histories and
physical examination. Nasal nitric oxide (NO) levels were measured in all subjects using
established techniques with a spirometer (model CLD 88; Eco Medics, Duernten,
Switzerland). Spirometry was performed on subjects aged ≥5 years. Sputum or
oropharyngeal swabs were collected for microbiological studies. Nasal epithelial scrapings
from inferior nasal turbinates were collected from several subjects for ultrastructural
analysis of ciliary axonemes,3,18 which revealed dynein arm defects. Blood or buccal cell
samples were collected for genetic analysis; DNA was extracted using commercially
available kits.17 The diagnosis of PCD was based on the presence of typical clinical features,
reduced nasal NO levels, and ultrastructural defects or disease-causing mutations of known
genes. The relevant Institutional Review Boards approved the studies, and signed informed
consent was obtained from all subjects and family members.
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Specimens were collected for DNA isolation from subjects with PCD and unaffected first-
and second-degree relatives with known consanguinity from Plain communities from
Arkansas, Illinois, Missouri, Pennsylvania, and Wisconsin. In addition, DNA from unrelated
Amish and Mennonite children with other genetic conditions without symptoms consistent
with PCD were analyzed, to determine the relative frequency of DNAH5 mutations in
Pennsylvania settlements.
DNA was extracted from blood or buccal swab specimens, and whole genome amplification
was performed when necessary to provide adequate genetic material for further analysis.
Genome-wide homozygosity mapping, using high-density single nucleotide polymorphism
arrays, was performed following established protocols.19 Targeted mutation analyses were
conducted by sequencing 9 exons of DNAH5 and DNAI1 using a clinical genetic panel
developed at the University of North Carolina at Chapel Hill, which was developed based on
results from large studies that showed at least 1 mutation present in the selected exons and
splice sites in DNAI1 (exons 1, 13, 16, and 17) and DNAH5 (exons 34, 50, 63, 76, and 77)
in most affected individuals in whom PCD was due to the mutations in those genes.8–12 This
panel reduced DNA sequencing from a total of 99 exons. When only a single mutation was
detected, all of the coding exons and splice sites were interrogated for the pertinent gene to
identify a possible second mutant allele. Moreover, if biallelic mutations were not detected,
at least 1 affected individual from that cohort was sequenced for all coding exons and splice
sites for DNAI1 and DNAH5, to detect any mutations in exons not covered initially.20
To investigate linkage with 9 candidate genes known to be involved in outer dynein arm
structure (DNAI1, DNAH5, DNAH11, DNAH9, DNAI2, DNAL4, DNCL1, DNLC2A, and
TCTEL1), affected individuals and family members from Midwestern Amish-Mennonite
communities were genotyped for polymorphic microsatellites within and flanking these
genes. Haplotypes were reconstructed such that recombinants could be visualized on
pedigrees.
Results
All of the subjects studied had classic features, and ultrastructural examination of the cliliary
axoneme revealed dynein arm defects in several affected individuals consistent with a
diagnosis of PCD (Table I). Identification of multiple members from several Amish families
from central Pennsylvania facilitated genome-wide homozygosity mapping, using high-
density single nucleotide polymorphism arrays. These analyses localized the disease locus to
chromosome 5 in a region containing a known PCD-causing gene, DNAH5. Sequencing
identified a nonsense mutation in exon 27, c.4348C>T (p.Q1450X), that was previously
reported in a patient of Swiss descent.21 All of the affected individuals from this cohort were
homozygous for this nonsense mutation (Figure, A; III4, V1, V4, V6, V7, V8, V9, and
V10). This variant was also found in 2 affected siblings from an apparently
nonconsanguineous Mennonite family in Arkansas (Figure, B; II2 and II3). Exomic analyses
of 102 unrelated children without PCD from Amish and Mennonite families in Pennsylvania
identified 18 missense or nonsense variants in DNAH5,11,12,21 including 1 subject
heterozygous for DNAH5 c.4348C>T (p.Q1450X) (Table II).
Resequencing of the DNAH5 coding region and flanking introns from subjects and family
members from a large Midwestern Amish-Mennonite community revealed compound
heterozygous DNAH5 mutations in 2 affected siblings: c.10815delT (p.P3606HfsX23) and
c.4348C>T (p.Q1450X) (Figure, C; VI4 and VI5); however, several other family members
with PCD did not have DNAH5 mutations. Genetic testing showed that 5 subjects (Figure,
C; V8, VI10, VI11, VII2, and VII3) were heterozygous for the founder DNAI1 mutation,
g.IVS1+2_3insT (c.48+2_3insT). Analyses of microsatellite genotype data confirmed that
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other affected individuals were disconcordant for microsatellite marker alleles at known
PCD loci, including those associated with DNAH5 and DNAI1, indicating an unidentified
PCD-causing mutation in a novel gene. Subsequently, whole-exome sequencing revealed an
autosomal recessive, nonsynonymous missense mutation in HEATR2 (p.L795P), an
uncharacterized gene not previously associated with ciliary assembly or function.22 Of note,
3 affected children were homozygous for the HEATR2 mutation and heterozygous for the
DNAI1 mutation (VI11, VII2, and VII3), further illustrating the complex genetic basis of
PCD in this community.
Discussion
PCD is a genetically heterogeneous, autosomal recessive disease resulting from impaired
ciliary function. The estimated incidence is 1 in 15 000–30 000 births,23,24 with an estimated
prevalence as high as 5% in children that have recurrent respiratory infections. Investigators
have identified 15 different genes that when mutated produce unambiguous clinical
phenotypes and in most cases ultrastructural defects of the ciliary axoneme.4,19,22,25,26
Arising from an Anabaptist movement, the Swiss Brethren, the endogamous Plain
communities of North America present unique opportunities to better understand the genetic
basis of PCD and identify new candidate genes. Relative isolation, detailed record keeping,
and consanguineous marriages make Amish families ideal for genetic studies. We found a
high prevalence of PCD in Amish settlements, based on classic clinical history, reduced
nasal NO levels, and ultrastructural defects of the cilia. Many individuals harbored
axonemal γ-dynein heavy chain DNAH5 mutations; affected individuals in Pennsylvania
Amish communities and 2 subjects from a Mennonite family in Arkansas were homozygous
for the nonsense c.4348C>T (p.Q1450X) mutation. Two Amish subjects from the
midwestern US had biallelic mutations of DNAH5, specifically c.4348C>T (p.Q1450X) and
frameshift c.10815dT (p.P3606HfsX23) mutations.
Homologous to HCγ in the biflagellated alga Chlamydomonas reinhardtii, DNAH5 is one of
the first genes to have been implicated with disease.11,12 Since the discovery of DNAH5 and
its involvement in PCD, more than 60 disease-causing mutations in the gene have been
identified. Previously, investigators from Europe and the North America reported that 53%
of patients with PCD and known outer dynein arm defects had mutations clustered in 6
exons of DNAH5,11 and DNAH5 is the most common gene linked to PCD with outer dynein
arm defects,11 although the actual frequency of these mutations may be lower than
reported.20
In addition, we previously shown that some affected individuals from the midwestern Amish
families were heterozygous for a founder mutation, g.IVS1+2_3insT (c.48+2_3insT) in
DNAI1 (Figure, C), the human ortholog of Chlamydomonas reinhardtii IC78 and the first
gene associated with PCD identified using the candidate gene approach.17 This variant was
not disease-causing in these families, because microsatellite marker analysis excluded
DNAI1. Moreover, a second mutation was not identified after whole-exome sequencing.17
Even though we found PCD-causing mutations in DNAI1 and DNAH5 in these Anabaptist
communities, most subjects in the midwestern Amish families had an unidentified mutation
in a novel gene. Whole-exome sequencing revealed a single autosomal recessive missense
mutation in HEATR2 (p.L795P). Airway epithelial cells isolated from individuals with PCD
had markedly reduced cytoplasmic HEATR2 levels, absent dynein arms, and virtually
immotile cilia. Recent analyses indicated a role in dynein arm transport and assembly.22
In conclusion, we have found that DNAH5 mutations are common to individuals with PCD
from socially and geographically isolated Amish and Mennonite communities in the US. In
Ferkol et al. Page 4













addition, we have identified a known DNAI1 splice mutation and novel missense mutation
in HEATR2 in these families. Taken together, a panel of these mutations could be a useful
diagnostic tool for such patients who present with clinical features consistent with PCD.
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Family pedigrees and genetic analyses. A, Consanguineous kindred with related nuclear
families in Amish communities from Pennsylvania. B, Mennonite family from Arkansas. C,
Amish-Mennonite family with children with PCD from several midwestern states, in which
affected individuals had 2 heteroallelic DNAH5 mutations. Solid symbols indicate affected
individuals; central dots, heterozygous individuals; dark-blue symbols, c.4348C>T
(p.Q1450X) DNAH5 mutation; light-blue symbols, c.10815delT (p.P3606HfsX23) DNAH5
mutation; yellow symbols, DNAI1 (g.IVS1+2_3insT) mutation; red symbols, HEATR2
(p.L795P) mutation. Arrows specify the probands. Asterisks indicate subjects who
underwent genetic testing. si, situs inversus totalis; sa, situs ambiguus
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